Archive - January 2018
Non-Commercial Clinical Trial: An Underappreciated Source of Clinical Investigators
USPTO to Remain Open during Government Shutdown
January 19 2018 – AstraZeneca’s R&D productivity makeover
Two Common Gene Mutations Boost Breast Cancer Risk, Scientists Find
New research paper shows that AstraZeneca has achieved greater than four-fold improvement in R&D productivity
AstraZeneca scores double approvals in Japan for asthma and ovarian cancer
Top Ten most popular articles on Pharmafile.com this week
Dermatology Biologics: Overcoming Challenges to Fulfill Therapeutic Potential